Cordyceps Sunshine Biotech Holdings Co., Ltd. — Operating Income by Fiscal Year
5 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/ef5a7f7a-67f6-4048-8c67-e2cf97efabab/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-141.1k | 2025-01-01 – 2025-12-31 | evidence 0001213900-26-057774 |
| FY 2024 | $-183.9k | 2024-01-01 – 2024-12-31 | evidence 0001213900-25-054317 |
| FY 2023 | $227.8k | 2023-01-01 – 2023-12-31 | evidence 0001213900-25-054317 |
| FY 2022 | $-415.1k | 2022-01-01 – 2022-12-31 | evidence 0001213900-24-059406 |
| FY 2021 | $-119.4k | 2021-01-01 – 2021-12-31 | evidence 0001213900-24-059406 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Cordyceps Sunshine Biotech Holdings Co., Ltd. — all facts · Revenue · Net Income